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Abstract There is growing evidence for a coupling of actin assembly and myosin motor activity
in cells. However, mechanisms for recruitment of actin nucleators and motors on specific
membrane compartments remain unclear. Here we report how Spir actin nucleators and myosin V
motors coordinate their specific membrane recruitment. The myosin V globular tail domain (MyoV-
GTD) interacts directly with an evolutionarily conserved Spir sequence motif. We determined
crystal structures of MyoVa-GTD bound either to the Spir-2 motif or to Rab11 and show that a Spir-
2:MyoVa:Rab11 complex can form. The ternary complex architecture explains how Rab11 vesicles
support coordinated F-actin nucleation and myosin force generation for vesicle transport and
tethering. New insights are also provided into how myosin activation can be coupled with the
generation of actin tracks. Since MyoV binds several Rab GTPases, synchronized nucleator and
motor targeting could provide a common mechanism to control force generation and motility in
different cellular processes.
DOI: 10.7554/eLife.17523.001
Introduction
Cytoskeletal filaments provide tracks for intracellular transport, an essential function for the organi-
zation, polarity and communication of eukaryotic cells. Polarized microtubules span the cytoplasm
and serve as tracks for fast long-range transport mediated by dynein and kinesin motors. Myosin
molecular motors have a functional area limited by the space in which F-actin tracks are found in
cells. The very dynamic nature of the actin cytoskeleton promotes transport on more flexible routes
beyond the microtubule network. Recent advances in understanding of the functional links between
cargos, myosins and actin assembly regulators demonstrate that they cooperate to accomplish spe-
cific membrane transport events (Cheng et al., 2012; Schuh, 2011; Sirotkin et al., 2005; Sun et al.,
2006). For example, the cooperation of class I myosin with the actin nucleator Arp2/3 complex is
required for membrane remodeling in endocytosis (Cheng et al., 2012; Sirotkin et al., 2005;
Sun et al., 2006). In mouse oocytes, actin nucleators Spir and formin-2 (FMN2) cooperate to gener-
ate actin filaments at Rab11 vesicle membranes, while myosin Vb (MyoVb) mediates the Rab11
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vesicle long-range transport towards the oocyte cortex at metaphase (Pfender et al., 2011;
Schuh, 2011). Moreover, nucleus positioning in mouse oocytes results from myosin V driven active
diffusion of Rab11 vesicles, which also requires Spir:formin-2 dependent actin polymerization on
these membranes (Ahmed et al., 2015; Almonacid et al., 2015).
However, the mechanism by which motors and actin nucleators are both specifically recruited to
membranes is poorly understood at present. Direct interaction between the membrane anchored
active Rab11 small GTPase and MyoV (MyoVa and MyoVb) globular tail domain (GTD) is necessary
to target the motor to Rab11 vesicles (Lapierre et al., 2001; Lindsay et al., 2013). In contrast, a
direct interaction between Spir and Rab11 could not be detected and it is still unclear how differen-
tial recruitment of the motors and the actin track regulators can be specified to promote Rab11-vesi-
cle transport. The Spir actin nucleators (Spir-1 and Spir-2 in mammals) encode a FYVE-type zinc
finger membrane-binding domain at their C-termini (Kerkhoff et al., 2001; Otto et al., 2000;
Tittel et al., 2015) that promiscuously interacts with negatively charged lipids (Tittel et al., 2015). It
has been proposed that the interaction of Spir proteins with additional factors provides the specific-
ity for its targeting to the correct subpopulation of vesicles (Tittel et al., 2015).
A search for the mechanism that controls the targeting of the Spir:FMN complex to Rab11:MyoV
vesicles revealed a conserved MyoV globular tail domain binding motif (GTBM) in Spir proteins that
mediates a direct interaction between Spir and MyoV. We have solved the crystal structures of the
MyoVa globular tail domain in complex with Spir-2-GTBM and in complex with Rab11. We have also
shown that the MyoV-GTD links Spir-2 and Rab11 into a tripartite complex in vitro and in cells. The
Spir:MyoV interaction contributes to the motor activation and to the coordination of the specific
membrane recruitment of both actin polymerization and motor machineries required for force pro-
duction powered by MyoV.
Results
Spir directly interacts with myosin V
To gain insights into whether the actin nucleator Spir and the motor MyoV could be both activated
in coordination on vesicle membranes, we first performed protein interaction studies to determine if
Spir and MyoV (Figure 1) coexist in a protein complex. Our initial GST-pulldown experiments
showed that GST-MyoVb-GTD is able to pull endogenous Spir-1 from mouse brain lysates, as does
the GST-FMN2-eFSI protein that binds directly to the Spir KIND domain (Pechlivanis et al., 2009) as
a positive control (Figure 2—figure supplement 1A). In co-immunoprecipitation (co-IP) experiments
employing human embryonic kidney cells transiently over-expressing recombinant Spir and MyoV,
the full-length Spir-1 and Spir-2 proteins did interact with the GFP-MyoVb-GTD (Figure 2A). We
mapped the Spir sequences necessary for the interaction with MyoVb by successive N-terminal dele-
tions of Spir-2. The deletion of KIND and WH2 domains did not affect complex formation; however,
further deletion of the linker region between the WH2 domains and the Spir-box (Figure 1)
completely impaired the interaction (Figure 2A), demonstrating that the Spir central linker region is
important for MyoVb-GTD binding. The GTDs of MyoVb and MyoVa are highly conserved
(Pylypenko et al., 2013) and both directly interact with Rab11 (Lindsay et al., 2013; Roland et al.,
2009). Interestingly, GFP-MyoVa-GTD also interacts with Spir-2 (Figure 2—figure supplement 1B).
This is consistent with the fact that MyoVa and MyoVb have overlapping cellular functions (such as
mobilization of Rab11 recycling endosomes for the AMPA receptor transport into dendritic spines
[Correia et al., 2008; Hammer and Wagner, 2013; Wang et al., 2008]), share interacting partners
and utilize similar mechanisms for Rab11-vesicle transport.
We confirmed a direct interaction of the two MyoV isoforms (MyoVa, MyoVb) and Spir by GST-
pulldown assays using purified recombinant proteins (Figure 2B). Further experiments showed that
both MyoVa and MyoVb bind the Spir-2-linker (aa 361–519) with similar affinities in the sub-micro-
molar range (Kd ~ 728 nM and 377 nM for MyoVa and MyoVb, respectively) (Figure 2C).
Evidence for Spir:MyoV complex formation at vesicle membranes
The detected tight binding of MyoV and Spir suggested that they would interact in cells. Transgenic
co-expression of tagged full-length MyoVa (eGFP-MyoVa-FL) and Spir-2 (Myc-Spir-2-FL) proteins in
HeLa cells showed a perfect colocalization of the two proteins on vesicular structures in the central
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cytoplasm, consistent with formation of a Spir:MyoV complex at vesicle membranes (Figure 3A).
This was also the case for MyoVb and Spir-2 (Figure 3B). In order to confirm a complex formation of
Spir-2 and MyoVa on vesicle membranes we performed FLIM-FRET (fluorescence life time imaging,
fluorescence resonance energy transfer) microscopy experiments (Sun et al., 2013) with co-
expressed AcGFP-MyoVa-GTD as a donor fluorophore and mStrawberry-Spir-2 deletion mutants as
acceptor fluorophores. A mStrawberry-tagged C-terminal Spir-2 protein (mStrawberry-Spir-2-GTBM-
SB-FYVE), including the Spir-GTBM (necessary for MyoV interaction), the Spir-box and the FYVE-
type zinc finger (Spir membrane interaction) is able to reduce the fluorescence lifetime of the
AcGFP-MyoVa-GTD donor at vesicle membrane surfaces (Figure 3C–E). In contrast, a mStrawberry-
fusion protein encoding only the Spir-box and the FYVE-type zinc finger (mStrawberry-Spir-2-SB-
FYVE) or a mutant Spir-2-GTBM-SB-FYVE-LALA protein, in which two essential leucines for MyoV
interaction were replaced by alanines, did not alter the lifetime of the AcGFP-MyoVa-GTD donor
(Figure 3E). As the lifetime reduction indicates that MyoVa and Spir-2 proteins are in close proximity
(within 10 nm of distance between the fluorophores), these results provide a strong support for a
direct interaction of the two proteins at vesicle membranes. The MyoVa-GTD is monomeric in
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Figure 1. Schematic overview of the Spir and MyoV protein fragments used in this study. The myosin V motor
domain and its 6 IQ lever arm is followed by a coiled-coil dimerization region and the C-terminal globular tail
domain. The central linker region of Spir connects the N-terminal KIND and four actin binding WH2 domains on
one side, with the C-terminal Spir-box (SB) and a membrane binding FYVE-type zinc finger on the other. The
newly identified Spir myosin V binding motif (GTBM) is located in the middle of the linker region. The domain
boundaries are indicated in the full-length MyoVa (containing exon D (D) or exon F (F)), MyoVb, Spir-1 and Spir-2
proteins. Numbers indicate amino acids. Stars indicate amino acid substitutions. FL, full-length; GTD, globular tail
domain; CC, coiled-coil; KIND, kinase non-catalytic C-lobe domain; GTBM, globular tail domain binding motif; SB,
Spir-box; LALA, L408,409A substitution. Species abbreviations are Hs, Homo sapiens; Mm, Mus musculus.
DOI: 10.7554/eLife.17523.002
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solution (Figure 5—figure supplement 2). To exclude a FLIM-FRET signal by a dense packing of
proteins at vesicle membranes, we co-expressed green and red-fluorescent protein tagged MyoVa-
GTDs as a donor/acceptor pair (AcGFP-MyoVa-GTD, mStrawberry-MyoVa-GTD) which revealed a
similar FRET efficiency as the donor alone (Figure 3E), indicating that a direct interaction of MyoVa-
GTD and the Spir-2-GTBM is required for the observed FLIM-FRET signal.
Identification of a conserved MyoV binding motif in Spir
The linker regions of vertebrate Spir-1 and Spir-2 proteins show low overall sequence homology (for
example similarity 21%, identity 11% between human Spir-1 and Spir-2 linker regions) (Figure 4—
figure supplement 1) but a short sequence of 27 amino acids (Figure 4A) in the middle part of the
linker is more conserved (similarity 56%, identity 37%) suggesting that the fragment could possibly
have an important role in the recruitment of MyoV. Interestingly, Spir-2 fragments containing the
fully conserved regions interact with MyoVb-GTD, whereas no interactions were observed with frag-
ments lacking half of this region (Figure 4—figure supplement 2). Mutation of two highly conserved
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Figure 2. Spir proteins directly interact with myosin V. (A) Co-immunoprecipitation assay of HEK293 cells
transfected with plasmids expressing AcGFP (GFP), AcGFP-tagged MyoVb deletion mutants and indicated Myc-
epitope tagged Spir-1 and Spir-2 proteins. Cell lysates were immunoprecipitated with anti-Myc antibodies. The
cell lysates (input) and immunoprecipitates (co-IP) were analyzed by immunoblotting with antibodies as indicated.
The Spir-2-GTBM and the MyoVb globular tail domain (GTD) were identified as being essential for the Spir/MyoV
interaction. N = 4 experimental repeats. WB, Western blotting. (B) GST-pulldown studies employing purified
bacterially expressed recombinant proteins to analyze a direct interaction of Spir-2-linker and MyoVa/Vb-GTD. The
mutation of two highly conserved leucines within the Spir-2-GTBM to alanines (human Spir-2-L408A, L409A; Spir-2-
linker-LALA, see also Figure 4A) largely impairs binding of this mutant to GST-MyoVa/Vb-GTD. N = 4
experimental repeats. (C) Fluorescence spectroscopy was used to determine the dissociation constants (Kd) for
MyoVa and MyoVb GTD binding to His6-mCherry-Spir-2-linker. Error bars represent SEM (n = 4 experimental
repeats).
DOI: 10.7554/eLife.17523.003
The following figure supplement is available for figure 2:
Figure supplement 1. Interaction of endogenous Spir-1 with MyoVb-GTD.
DOI: 10.7554/eLife.17523.004
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Figure 3. Myosin V and Spir-2 interact at vesicle membranes. (A and B) GFP-tagged full-length MyoVa (eGFP-
MyoVa-FL; green; A) and MyoVb (AcGFP-MyoVb-FL; green; B) colocalize with Myc-epitope-tagged full-length Spir-
2 (Myc-Spir-2; red) at vesicle membranes when transiently co-expressed in HeLa cells as indicated by overlapping
punctae (merge; yellow; higher magnification in insets). 5 cells were recorded and one representative cell is
Figure 3 continued on next page
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Spir-2 residues within this newly identified Spir linker homology region, Leu408Ala and Leu409Ala, is
sufficient to abolish direct binding to MyoV-GTD (Figure 2B). The identified minimal MyoV globular
tail domain binding motif of Spir (Spir-GTBM), corresponding to the human Spir-2 short peptide (aa
401–427) binds MyoVa and MyoVb GTDs with low micromolar affinity (Figure 4B).
Spir binding site is conserved in all three MyoV isoforms
We further characterized the Spir:MyoVa binding by solving a crystal structure of the complex, which
allowed us to identify the protein interaction sites and depict the stabilizing interactions within the
complex at atomic detail (Figure 4C, Table 1). Importantly, the Spir residues important for the inter-
action with MyoV-GTD are conserved among Spir proteins (Figure 4A). The MyoV-GTD is composed
of two closely apposed subdomains (SD-1 and SD-2) (Figure 4C). The Spir-2-GTBM peptide binds to
the SD-1 of the MyoVa-GTD in an extended conformation, forming a two-turn alpha helix at the
end, in the cleft between helices H3 and H5 (Figure 4C,D). Spir-2-GTBM can be accommodated on
the surface of MyoVa without conformational changes in the GTD (Figure 4—figure supplement
3A,B), and the Spir-GTBM binding pocket is structurally conserved in MyoVb and MyoVc (Figure 4—
figure supplement 3C,D). Consistently, a direct binding assay also showed that MyoVc-GTD binds
Spir-2-GTBM with micromolar range affinity (Figure 4—figure supplement 3E). We thus conclude
that the Spir-binding site structural conservation of the three myosin V isoforms explains Spir promis-
cuity in binding to MyoVa, Vb and Vc.
Spir and melanophilin bind to the same MyoVa pocket, but use
different interaction modes
Interestingly, the MyoV-GTD Spir-2 binding site partially overlaps with that of melanophilin (MLPH)
(Pylypenko et al., 2013; Wei et al., 2013) (Figure 4D,E). Both Spir-2-GTBM and MLPH-GTBM bind
the MyoVa-GTD with similar micromolar range affinities (Figure 4B) (Pylypenko et al., 2013). How-
ever, in contrast to the Spir-GTBM, which interacts with all three MyoV isoforms, the MLPH-GTBM
binding is MyoVa specific (Wei et al., 2013; Pylypenko et al., 2013). The Spir-2 and MLPH GTBMs
exhibit some sequence similarity (Figure 4F) and comparison of the complex structures shows that
their N-terminal regions interact with MyoVa in a very similar way, forming a network of hydrogen
bonds with the H4’’-H5-loop and similarly positioning two conserved leucine residues of the motif
(L408 and L409 in Spir-2; L188 and L189 in MLPH) within cavities of the MyoVa-GTD surface
(Figure 4D,E,H). As mentioned above, mutation of the two highly conserved Spir leucine residues to
alanines significantly impairs Spir-2 binding to MyoV (Figure 2B). The Spir-GTBM C-terminal part
anchors itself in the MyoVa hydrophobic cleft between helices H3 and H5 using L414 and M417 side
chains; and the small side chain of the strictly conserved Ala411 binds in proximity to the MyoVa
Tyr1596 side chain (Figure 4D,G). The apo-MyoV-GTD surface is preformed to bind Spir-GTBM
(Figure 4G,H). In contrast to Spir-GTBM, the MLPH-GTBM cannot be accommodated on the surface
Figure 3 continued
presented here. Scale bars represent 10 mm. (C–E) FLIM-FRET analysis of transiently expressed AcGFP-tagged
MyoVa-GTD (AcGFP-MyoVa-GTD, donor) and mStrawberry-tagged C-terminal Spir proteins (acceptors) at vesicle
membranes in HeLa cells. (C, D) Examples demonstrating the lifetime shift due to FRET. Confocal fluorescence
images (green channel, AcGFP; red channel, mStrawberry; and fluorescence lifetime images of AcGFP) of AcGFP-
MyoVa-GTD expressed alone (C) and in the presence of the interacting acceptor protein mStrawberry-Spir-2-
GTBM-SB-FYVE (D) are shown. (E) The average FRET efficiencies per cell measured at vesicle membranes for the
indicated transiently expressed donor-acceptor combinations are presented in a box-and-whisker plot. Every dot
represents a single cell. The region of interest was manually confined to the cytoplasm (average FRET efficiencies
for AcGFP alone and the tandem AcGFP-linker-mStrawberry). For all other experiments, the ROI was further
reduced by a threshold algorithm that identifies vesicles in the AcGFP channel. Box-and-whisker plots indicate 2nd
and 3rd quartile (box), median (red horizontal line, value noted above each box), and 1.5x interquartile range
(whiskers). 10–15 cells have been analyzed for each transfection.
DOI: 10.7554/eLife.17523.005
The following source data is available for figure 3:
Source data 1. Source data for FLIM-FRET analysis of MyoVa and Spir-2 expression at vesicle membranes.
DOI: 10.7554/eLife.17523.006
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Figure 4. A conserved sequence motif of Spir binds to MyoV-GTD. (A) A short highly conserved sequence motif
within the central Spir linker region is responsible for myosin V binding. Alignment of vertebrate Spir-1 and Spir-2
sequence fragments. The short sequence motif of about 27 amino acids in the middle part of the Spir linker region
shows high sequence homology (see also Figure 4—figure supplement 1). Species abbreviations: Homo sapiens
(Hs), Mus musculus (Mm), Gallus gallus (Gg), Xenopus tropicalis (Xt), Brachydanio rerio (Br). All sequence-related
data are available through CyMoBase (http://www.cymobase.org). Hs-Spir-2 residues contacting MyoVa within 4 A˚
distance are labeled with ’*’; the Spir-2 conformation is stabilized by two conserved residues (see panel D)
indicated with ’+’. (B) Fluorescence anisotropy measurements of the binding of the Fluorescein-Spir-2-GTBM
peptide (human, amino acid residues 401–427) to the MyoVa and MyoVb GTDs. The equilibrium dissociation
constants (Kd) for MyoVa and MyoVb GTDs were determined by fitting the titration curves as detailed in the
Materials and Methods section. The experiments were repeated twice with two different protein preparations. (C)
Crystal structure of the MyoVa-GTD:Spir-2-GTBM complex. Spir-2-GTBM (purple) binds to subdomain-1 (SD-1) of
MyoVa-GTD (orange). (D) Close-up view of the Spir-2-GTBM bound to MyoVa-GTD. Residues forming the
interaction sites are shown as sticks and are labeled. Spir-2 E416 and T413 form intramolecular hydrogen bonds
(dashed lines). Spir-2 V407, L409 and MyoVa N1590 and D1592 backbone atoms form an intermolecular b-structure
like hydrogen bond network. (E) MLPH-GTBM bound to MyoVa-GTD (PDB ID 4LX2). The N-terminal part of MLPH-
GTBM (residues from K186 to L189) interacts with MyoVa in a similar manner to Spir-2 (residues 406–409). A similar
Figure 4 continued on next page
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of apo-MyoVa-GTD without conformational changes (Figure 4H). MLPH-GTBM has a conserved
hydrophobic residue (Phe, Ile or Val) Phe191 at the position equivalent to the Spir-2-A411
(Figure 4E,F,H) and its binding to MyoVa requires rotation of the Tyr1596 side chain in towards the
protein core to harbor the big Phe side chain in the binding pocket (Figure 4H,I; Figure 4—figure
supplement 4). As proposed previously (Pylypenko et al., 2013), the conformational change
required for MLPH binding is likely more difficult to achieve in other MyoV isoforms due to the
sequence differences in the protein core surrounding the Tyr1596. Moreover, the MyoVa Arg1528
that stabilizes the MLPH-GTBM by two hydrogen bonds (Figure 4E) is not conserved in the myosin
V isoforms and contributes to the MyoVa binding specificity (Wei et al., 2013). The observed differ-
ences in how Spir-2-GTBM and MLPH-GTBM bind to MyoV-GTD thus account for their discrepancy
in binding specificity.
Common features of GTBM
The globular tail domain of MyoV thus binds different partners using the same binding site. Interest-
ingly, Spir-GTBM and MLPH-GTBM have a similar distribution of charged residues along the
sequence: their N-terminal part is positively charged, and their C-terminal sequence, after the spe-
cific binding motif, contains a cluster of negatively charged residues (Figure 4—figure supplement
5). Thus, Spir-2-GTBM binding to MyoV also likely use the charge complementarity described for
MLPH-GTBM binding to MyoVa (Pylypenko et al., 2013). The low amino acid complexity within the
GTBM makes it very difficult to generate a reasonable binding motif profile that can be used for a
search of other GTBM containing proteins against protein sequence databases. Unfortunately, our
attempts to find other proteins potentially capable of MyoV binding failed. However, the polypep-
tide chain recognized by the GTD has three characteristic properties as follows: (1) the clusters of
charged residues may help to orient the peptide relative to the GTD surface, (2) the extended N-ter-
minal region is able to form hydrogen bonds with backbone atoms of the GTD, and (3) the hydro-
phobic residues of the motif provide the peptide anchoring in small surface pockets of the GTD.
In summary, we identified a new functional region in Spir and provide an atomic description of
how Spir proteins interact with the GTD of MyoV motors, which brings critical insights into the com-
patibility or competition of Spir binding with different MyoV cargos and their ability to regulate
MyoV activity.
Figure 4 continued
hydrogen bond between MyoVa E1595 and the main chain nitrogen of MLPH F191 is also observed in the Spir-2:
MyoVa interface. (F) Structure based sequence alignment of the Spir-2-GTBM and MLPH-GTBM fragments.
Residues making similar contacts with MyoVa are highlighted with a black line. (G) Hydrophobic residues
anchoring Spir-2-GTBM on the MyoVa-GTD surface. Spir-2 A411 is packed on the top of MyoVa Y1596 (green) side
chain (see also panel D). (H) Spir-2 (purple) and MLPH (gray) GTBMs docked on the surface of apo-MyoVa-GTD
(PDB ID 4LX1). The apo-MyoVa-GTD hydrophobic cleft between the H5 and H3 is compatible with Spir-2 binding,
but not with MLPH, where the side chain of F191 clashes with MyoVa Y1596 (green). In Spir, the conserved L414
side chain anchors the C-terminal Spir-2 fragment extending the interacting hydrophobic surface compared to
what is found for MLPH-GTBM binding. (I) Hydrophobic residues anchoring MLPH-GTBM in the MyoVa-GTD
pocket (PDB ID 4LX2). The MyoVa Y1596 (green) side chain is rotated to bury the side chain within the protein core
(see also panel E) to accommodate MLPH F191 in the binding pocket.
DOI: 10.7554/eLife.17523.007
The following figure supplements are available for figure 4:
Figure supplement 1. Gene and protein sequence structures of vertebrate Spir.
DOI: 10.7554/eLife.17523.008
Figure supplement 2. Mapping of the Spir-2 myosin binding domain.
DOI: 10.7554/eLife.17523.009
Figure supplement 3. Comparison of myosin V isoforms Spir/MLPH binding sites.
DOI: 10.7554/eLife.17523.010
Figure supplement 4. MyoVa conformational change upon MLPH binding.
DOI: 10.7554/eLife.17523.011
Figure supplement 5. Structural similarities of Spir and melanophilin.
DOI: 10.7554/eLife.17523.012
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A tripartite Spir:MyoV:Rab11 complex determines Spir membrane
specificity
To gain insights into the relationship between Spir, MyoV and Rab11, we solved the crystal structure
of Rab11a bound to the MyoVa-GTD. This structure confirms that Rab11a binds to the MyoVa-GTD
SD-2, as previously reported for the MyoVb:Rab11a complex structure (Pylypenko et al., 2013) and
indicates that some structural variability in Rab11a occurs upon its binding to the MyoV isoforms
(Figure 5—figure supplement 1, Table 1). The structures of MyoVa:Spir-GTBM and MyoVa:Rab11a
demonstrate that the Rab11 and Spir binding sites are on opposite ends of the elongated MyoV-
GTD while the GTD adopts a similar conformation in the two binary complexes. This implies that the
two MyoV partners can bind to the GTD at the same time, as shown in a model of the tripartite com-
plex (Figure 5A). The organization of the tripartite complex, where MyoV links Spir to Rab11, pro-
vides an explanation of how Spir proteins can be specifically targeted to Rab11 vesicles.
To reveal the existence of the tripartite complex in vitro and in vivo, several experiments were
designed. First, we showed that bacterially expressed constitutively active GST-Rab11a-Q70L pulls
down transiently over-expressed full-length MyoVa, Spir-2 and a C-terminal FMN2 protein (mStraw-
berry-FMN2-FH2-FSI) from HEK293 lysates (Figure 5B); over-expressed MyoVa-Q1753R mutant
impaired in Rab11 binding (Lindsay et al., 2013) affects all three proteins co-precipitation with the
GST-Rab11a-Q70L-beads consistent with the role of MyoV for linking the MyoV:Spir:FMN2 complex
to Rab11.
GST-pulldown experiments with recombinant proteins using GST-Spir-2-GTBM-SB-FYVE also con-
firm that MyoV serves as a linker between Spir and Rab11. In the absence of the MyoVa-GTD, Spir
does not pull down Rab11a-Q70L (Figure 5E). The tripartite complex formation was further
Table 1. X-ray diffraction data collection and structure refinement statistics.
MyoVa-GTD:Rab11 MyoVa-GTD:Spir2
Data collection
X-ray source SOLEIL PX1 SOLEIL PX1
Space group C 1 2 1 C 1 2 1
Cell dimensions
a, b, c [A˚]
a, b, g [˚]
215.79, 128.42, 89.02
90, 98.27, 90
99.61, 41.22, 108.22
90, 115.89, 90
Resolution [A˚] 48.88–2.056
(2.18–2.056)
44.81–1.76
(1.86–1.76)
Rsym 5.3 (55.5) 7.4 (60.0)
I / sI 20.6 (3.38) 15.7 (2.5)
Completeness [%] 98.59 (97.0) 99.77 (99.75)
Redundancy 7.7 (7.6) 6.4 (6.2)
Refinement
Resolution [A˚] 48.88–2.056
(2.129–2.056)
44.81–1.8
(1.864–1.8)
No. of reflections 146774 (14323) 36967 (3659)
Rwork / Rfree 17.97 / 20.83
(23.00 / 26.6)
15.13 / 19.13
(27.49 / 36.49)
Number of atoms in AU
Protein/ligand/solvent
12516 / 172 / 1154 3191 / / 432
Average B-factor 60.5 31.9
r.m.s.d
bond lengths [A˚]
angles [˚]
0.002
0.59
0.01
1.092
PDB ID 5JCZ 5JCY
DOI: 10.7554/eLife.17523.013
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Figure 5. Myosin V links Spir-2 and Rab11 into a tripartite complex. (A) A model of the Rab11a:MyoVa-GTD:Spir-2-
GTBM complex was generated by superimposition of the MyoVa-GTD from the two crystal structures Rab11a:
MyoVa-GTD and MyoVa-GTD:Spir-2-GTBM. The Spir-2-GTBM (purple) binds to the SD-1 of the MyoVa-GTD
(orange) and Rab11a (green, Switch-1 blue, Switch-2 red) binds to its SD-2. (B) GST-pulldown assay with purified
GTP-locked GST-Rab11a-Q70L mutant and HEK293 cell lysates transiently over-expressing full-length Myc-
epitope-tagged Spir-2 (Myc-Spir-2), mStrawberry-tagged C-terminal formin-2 (Straw-FMN2-FH2-FSI), eGFP-tagged
full-length MyoVa (GFP-MyoVa-FL) or eGFP-tagged full-length MyoVa with the Q1753R mutation, which disrupts
interaction with Rab11, (GFP-MyoVa-Q1753R). GST-Rab11a-Q70L is able to pull GFP-MyoVa-FL from cell lysates,
but not the GFP-MyoVa-Q1753R mutant. In the presence of GFP-MyoVa-FL, GST-Rab11a-Q70L is also able to pull
down Myc-Spir-2, as well as Straw-FMN2-FH2-FSI. Only faint Myc-Spir-2 and Straw-FMN2-FH2-FSI bands were
detected with the GFP-MyoVa-Q1753R mutant. N = 2 experimental repeats. (C) The localization of transiently co-
Figure 5 continued on next page
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supported by analytical gel filtration experiments showing co-elution of all three proteins (Rab11a-
Q70L, MyoVa-GTD, mCherry-Spir-2-linker) (Figure 5—figure supplement 2).
Fluorescence microscopy of immunostained (Myc-Spir-2-GTBM-SB-FYVE) and fluorescent proteins
(eGFP-MyoVa-CC-GTD, mStrawberry-Rab11a) revealed that the three proteins have a nearly perfect
colocalization when transiently co-expressed in HeLa cells (Figure 5C,D). The strong colocalization
of Spir and Rab11 was dependent on the Spir MyoV binding motif. The Spir-2-SB-FYVE fragment,
that lacks the MyoV binding motif, showed membrane localization driven by the FYVE domain
(Tittel et al., 2015). When co-expressed with Rab11a and the MyoVa-CC-GTD, a significant reduc-
tion in Spir-2-SB-FYVE colocalization with Rab11 was observed, while colocalization of Rab11 with
MyoVa-CC-GTD remained high (Figure 5C,D). These data strongly support that MyoV acts as an
adapter to target Spir actin nucleators specifically towards Rab11 vesicle membranes.
Spir activates Rab11 dependent MyoV membrane targeting
MLPH-GTBM binding to the MyoVa-GTD promotes a structural rearrangement in myosin Va in vitro
whereby it switches from an inhibited ’OFF’ conformation (Figure 6A,B) in which the GTD folds back
and binds to the motor domain, to an extended active ’ON’ conformation (Yao et al., 2015). Inter-
estingly, the Spir and MLPH binding site also overlaps with the MyoVb-GTD N-terminal linker inter-
action site that has been proposed to contribute to the MyoV OFF state stabilization
(Pylypenko et al., 2013) (Figure 6A). The obvious structural similarity between Spir-GTBM and
MLPH-GTBM binding to the MyoVa-GTD suggests that Spir could similarly play a role in MyoV acti-
vation by disrupting the head-tail interaction and opening of the motor.
Full-length MyoVa transiently expressed in cells has an even cytoplasmic distribution (Figure 6C)
(Lindsay et al., 2013), indicating that the endogenous Rab11 binding activity by itself is not suffi-
cient to target the inhibited motor protein to vesicle membranes. To investigate if the interaction of
full-length MyoVa with the Spir-GTBM contributes to the activation of the motor protein we co-
expressed full-length MyoVa (eGFP-MyoVa-FL) and the N-terminal Spir-2 proteins in HeLa cells
(Figure 6D). When expressed alone, the N-terminal Spir-2 proteins (Spir-2-KIND-WH2; Spir-2-KIND-
WH2-GTBM) have an even cytoplasmic and nuclear localization (Figure 6C). Co-expressed MyoVa
and the N-terminal Spir-2 lacking the GTBM (Myc-Spir-2-KIND-WH2) are also both cytosolic
(Figure 6D). This is consistent with MyoV being in the inhibited state and not interacting with Spir-
KIND-WH2. In contrast, when full-length MyoVa is co-expressed with a Spir-2 fragment containing
the Spir-GTBM (Myc-Spir-2-KIND-WH2-GTBM), both proteins localize to vesicle membranes. This is
Figure 5 continued
expressed tagged Rab11 (mStrawberry, mStraw-Rab11; red), MyoVa-CC-GTD (eGFP, eGFP-MyoVa-CC-GTD;
green) and the Myc-epitope tagged (Myc, cyan) C-terminal Spir-2 proteins encoding (Myc-Spir-2-GTBM-SB-FYVE)
or lacking (Myc-Spir-2-SB-FYVE) the MyoV binding motif was analyzed by fluorescence microscopy. Deconvoluted
pictures indicate the localization of the proteins on vesicular structures. Scale bars represent 5 mm. 5 cells were
recorded for each condition and the cytoplasmic region of one representative cell is presented here. (D) The
colocalization of tagged proteins as described in (C) was quantified for the indicated co-expressions by
determining its Pearson’s correlation coefficient (PCC) as shown in a bar diagram. Each bar represents the mean
PCC value for at least 4 cells analyzed. Error bars represent SEM. Statistical analysis was done using Student’s
t-test to compare two co-expression conditions with a confidence interval of 95%. *p<0.05. Figure 5D. (E) GST-
pulldown assay engaging purified GST-tagged Spir-2-GTBM-SB-FYVE protein, purified MyoVa-GTD and the
purified GTP-locked Rab11a-Q70L mutant. GST-Spir-2-GTBM-SB-FYVE alone does not interact with Rab11a-Q70L.
In contrast, the presence of the MyoVa-GTD allows GST-Spir-2-GTBM-SB-FYVE to pull Rab11a-Q70L, as indicated
by immunoblotting with antibodies recognizing MyoVa and Rab11a. N = 3 experimental repeats.
DOI: 10.7554/eLife.17523.014
The following source data and figure supplements are available for figure 5:
Source data 1. Source data for calculation of mean PCC values for colocalization analysis.
DOI: 10.7554/eLife.17523.015
Figure supplement 1. Rab11 binds to MyoVa-GTD at the same site as to MyoVb-GTD, but adopts a different
conformation in the two complexes.
DOI: 10.7554/eLife.17523.016
Figure supplement 2. The MyoVa-GTD links Rab11 and Spir-2-linker into a tripartite complex.
DOI: 10.7554/eLife.17523.017
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Figure 6. Spir-2 facilitates myosin V recruitment to vesicle membranes. (A) A putative interaction mode of the
GTDs within the MyoV off state was derived from the MyoVb-GTD structure (PDB ID 4LX0). Two GTDs interact with
each other via N-terminal linkers occupying the Spir/MLPH binding pockets on the neighboring GTD, Spir and
MLPH GTBMs are shown in ribbon. (B) Schematic representation of myosin V activation by GTBM binding. (C and
D) N-terminal Spir fragments target MyoVa to vesicle membranes. (C) N-terminal Spir fragments (Myc-Spir-2-KIND-
WH2, Myc-Spir-2-KW; Myc-Spir-2-KIND-WH2-GTBM, Myc-Spir-2-KWM) and full-length MyoVa motor proteins
(eGFP-MyoVa-FL, eGFP-MyoVa-FL-Q1753R) have an even cytoplasmic and nuclear localization when transiently
expressed in HeLa cells (single expression). At least 5 cells were recorded for each condition and one
representative cell is presented here. Scale bars represent 10 mm. (D) Expression of full-length GFP-tagged MyoVa
(eGFP-MyoVa-FL; green (middle) and as heat map (left)) shows an even cytoplasmic distribution that is not
changed by co-expression of the Spir-2 fragment (Myc-Spir-2-KIND-WH2), which is not able to bind to MyoV and
Figure 6 continued on next page
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consistent with a model in which Spir-GTBM binding to cytosolic MyoV activates the motor and pro-
motes its membrane recruitment.
The vesicular localization of the full-length MyoVa triggered by Spir-2-GTBM binding was Rab11
dependent, since a MyoVa point mutant that cannot interact with Rab11 (MyoVa-Q1753R)
(Lindsay et al., 2013) fails to be targeted to vesicle membranes and shows an even cytoplasmic dis-
tribution, when co-expressed with the Spir-2-KIND-WH2-GTBM protein (Figure 6D). The experi-
ments demonstrate a Rab11-dependent coordinated membrane targeting mechanism of Spir and
MyoV (Figure 7).
Discussion
The timing and mechanism of motor recruitment to specific vesicles is vital for cellular function and
its intracellular organization. Targeted recruitment of either dynein, kinesins or myosins to vesicles is
the essential first step in sorting intracellular cargo within cells yet the logistics of motor activation
and vesicle localization are poorly understood. Rab11 GTPases recruit several different molecular
motors to vesicles, regulating trafficking of exocytic and recycling vesicles along microtubule and
actin tracks (Welz et al., 2014). The actin nucleator Spir is also present on the surface of Rab11-
vesicles, enabling them to generate their own tracks for transport by MyoV (Schuh, 2011). Here it is
revealed how the activation of Spir actin nucleators and MyoV actin-based motors on Rab11 vesicles
are coordinated.
The full-length MyoV motor is maintained in a folded, autoinhibited OFF state by an interaction
between the N-terminal motor domain and the C-terminal GTD. Relief of this interaction by cargo or
calcium binding abrogates head-tail binding, resulting in an extended, activated motor (Li et al.,
2008; Liu et al., 2006; Thirumurugan et al., 2006) (Figure 6B). The MyoV motor domain and
Rab11 compete for binding to the GTD since the surfaces involved in these interactions are in part
overlapping (namely the H11- H12 loop; Figure 6—figure supplement 1). This explains why the
membrane-anchored Rab11 GTPase alone is not sufficient to target the cytosolic inhibited MyoV to
Rab11 positive vesicles in vivo (Lindsay et al., 2013). However, a drastic change in the localization
of MyoV, from cytosol to membranes, occurs when the cellular concentration of Spir-GTBM is
increased (Figure 6D) strongly implicating Spir in the recruitment and activation of MyoV on Rab11
vesicles.
The Spir-GTBM interacts with the same binding pocket in the MyoV-GTD SD-1 (Figure 6A) that
can also be occupied by a short N-terminal linker preceding the MyoV-GTD implicated in stabilizing
the OFF state of the myosin (Pylypenko et al., 2013; Zhang et al., 2016). Binding of the Spir-GTBM
would displace the N-terminal linker and contribute to MyoV activation. MyoV activation is thus pre-
dicted to involve a competition between inter-GTDs stabilizing interactions within the motor OFF
state and Spir binding to SD-1. The Spir and MLPH GTBMs share an overlapping binding site, sug-
gesting that MLPH could activate MyoV in a manner similar to Spir. Thus, the Spir/MLPH binding site
Figure 6 continued
lipid membranes (upper panel). In contrast, co-expression of a myosin V binding Spir-2 fragment (Myc-Spir-2-
KIND-WH2-GTBM; red, middle panel) leads to targeting of MyoVa to vesicle membranes and to overlapping Spir-
2 and MyoVa localization (higher magnification insets). Heat maps represent grey values for MyoVa fluorescence
intensities rising from ’0’ (black) to ’4096’ (red) to document equal expression levels of MyoVa proteins in the
depicted cells. To address Rab11 dependence on motor protein targeting, the GFP-tagged melanocyte specific F
isoform of the Q1753R mutant MyoVa (eGFP-MyoVa-QR) that does not bind Rab11 was expressed. The expressed
MyoVa mutant has an even cytoplasmic distribution that was not changed upon co-expression of the myosin V
binding Spir-2 fragment (Myc-Spir-2-KIND-WH2-GTBM; red, lower panel). Representative cells are shown. All cells
observed under single and co-expression conditions had a vesicular or cytoplasmic localization as shown by the
representative cells presented here. 5 cells were recorded for each condition and one representative cell is
presented here. Scale bars represent 10 mm.
DOI: 10.7554/eLife.17523.018
The following figure supplement is available for figure 6:
Figure supplement 1. Rab11 binding may affect the GTD:motor-domain interaction in the folded inhibited state
of MyoV.
DOI: 10.7554/eLife.17523.019
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likely represents a MyoV activation hot spot. Further evidence and detail on the mechanism of MyoV
activation by cargo awaits future structural studies on the MyoV OFF state and on other GTD-bind-
ing partner interactions.
The data presented here reveal a mechanism for how both MyoV and Spir increase their mem-
brane colocalization and work cooperatively during vesicle transport. Spir proteins are also predicted
to exist in a folded state in the cytoplasm. Promiscuous binding of the Spir-FYVE to negatively
charged phospholipids is thought to promote an open conformation of the protein (Tittel et al.,
2015), facilitating formin recruitment and assembly of an active Spir:FMN complex that promotes
actin nucleation on vesicles. Together, the vesicle-bound Spir and Rab11 could then synergistically
activate and recruit MyoV. The resulting membrane bound tripartite complex then coordinates
nucleation of F-actin tracks and myosin force generation on a subset of Rab11 vesicles. This enables
MyoV-driven motility in regions of the cell distal from the cortical actin network, such as in the
oocyte cytoplasm (Schuh, 2011) and most likely in the central region of somatic cells. The newly syn-
thesized actin filaments emanating from vesicles would also favor MyoV-dependent motility as this
myosin has been found to have both an increased landing rate and run lengths on ADP-Pi actin fila-
ments (Zimmermann et al., 2015) and facilitate actomyosin mediated transport of vesicles towards
microtubule tracks (Dietrich et al., 2013).
The exact timing and order of events required to assemble the Spir:MyoV:Rab11 tripartite com-
plex remains to be established. Precisely defining the steps that activate and recruit MyoV and Spir
to Rab11 positive vesicles will require analysis of proteins expressed at endogenous levels. The use
of novel gene editing technology in combination with the next generation of fluorescent proteins
(e.g. mNeonGreen) (Shaner et al., 2013) should enable the generation of cell lines for quantification
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Figure 7. A model of a coordinated assembly of the Spir/FMN F-actin nucleator complex and myosin V motor
proteins at Rab11 vesicle membranes. Spir and MyoV proteins adopt a backfolded autoinhibited conformation in
the cytoplasm (Li et al., 2008; Liu et al., 2006; Thirumurugan et al., 2006; Tittel et al., 2015). A non-specific
transient interaction of the Spir FYVE-type domain with membranes opens up Spir (Tittel et al., 2015). Spir-GTBM
binding to the inhibited MyoV contributes to the release of MyoV autoinhibition and facilitates MyoV-GTD
interaction with Rab11 at vesicle membranes, further stabilizing the MyoV activated extended conformation. The
Spir-FYVE membrane interaction releases the cis-regulatory KIND/FYVE domain interaction and subsequently
allows formin (FMN) dimer recruitment at the membranes (Tittel et al., 2015). Interaction with the formin dimer
promotes Spir dimerization and allows efficient F-actin nucleation (Dietrich et al., 2013; Namgoong et al., 2011;
Quinlan et al., 2007). Note that the order of events is not known and will require further studies. The domain
structures of the Spir and MyoV proteins are indicated by the same color code as in Figure 1 (Spir: FYVE, red;
Spir-box, yellow; GTBM, purple; WH2, light blue; KIND, dark blue; MyoV: GTD, orange; coiled coil, calmodulin
bound IQ motifs and motor domain, gray).
DOI: 10.7554/eLife.17523.020
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of endogenous protein concentration at vesicle membranes, analysis of the fluctuations of Spir,
FMN, MyoV and Rab11-FIP2 at Rab11 vesicle membranes and correlation of complex dynamics with
vesicular motility and the morphological dynamics of the vesicles.
The mechanism for cooperative membrane recruitment of Spir and MyoV via interaction with a
Rab described here serves as a paradigm for how cells can generate actin-based transport of a range
of membrane vesicles. Specifically, the insights revealed here into how Spir interacts with MyoV iden-
tify a new role for Spir as a critical regulator of MyoV recruitment and activation. Different splice
forms and variants of Spir and MyoV are implicated in a wide range of cellular functions, and MyoV
interacts with an array of Rab GTPases with roles in a range of transport processes (e.g. Rab3, Rab8
and Rab 32; [Bultema et al., 2014; Lindsay et al., 2013; Roland et al., 2011]). This suggests the
possibility that Spir:MyoV complexes might be recruited via Spir and Rab membrane interactions to
a number of different membrane compartments for transport along their own self-generated local
actin network. For example, a splice form of Spir-1 (Spire1C) is specifically localized to
the mitochondria (Manor et al., 2015) and it is tempting to speculate that it plays a role in recruiting
MyoV that has been implicated in regulating the trafficking of this organelle (Pathak et al., 2010;
Schwarz, 2013; Sheng, 2014). Interestingly, it has previously been shown that a class I myosin
recruits the Arp2/3 actin nucleator complex to membranes during endocytic vesicle formation
(Cheng et al., 2012). Together with the identification here of a tripartite Spir:MyoV:Rab11 complex
that recruits formins to membranes, coordination of actin nucleation and myosin motors is likely to
be a general strategy used by cells to promote myosin dependent motility of membranes.
Materials and methods
Identification and assembly of Spir sequences
The Spir genes were identified by TBLASTN (RRID: SCR_011822) searches against the respective
sequenced eukaryotic genomes. The published sequences of Drosophila Spir and human Spir were
taken as seeds. All hits were manually analyzed at the genomic DNA level by comparing the three
reading frame translations to the multiple sequence alignments of all Spir proteins to reveal homolo-
gous regions missing in gene predictions. If available for a certain species, EST data from the NCBI
EST database has been analyzed to help in the annotation process. All sequence-related data and
references to genome sequencing centers are available through CyMoBase (http://www.cymobase.
org).
Cloning of bacterial and mammalian protein expression vectors
Prokaryotic and eukaryotic expression vectors were generated by standard cloning techniques using
Pfx DNA polymerase (AccuPrime; ThermoFisher, Waltham, MA, USA), restriction endonucleases
(New England Biolabs (NEB), Frankfurt am Main, Germany) and T4 DNA ligase (NEB). Point mutants
were generated using the QuikChange site-directed mutagenesis kit (Agilent Technologies (former
Stratagene), Santa Clara, CA, USA) and Pfu DNA polymerase (Promega, Mannheim, Germany).
Sequence correctness was verified by sequencing (LGC Genomics, Berlin, Germany). A detailed
overview of all expression vectors employed in this study is presented in Table 2.
Recombinant protein production for structural studies and interaction
measurements
Recombinant GST-MyoVa-GTD, GST-MyoVb-GTD, GST-Spir-2-GTBM-SB-FYVE, GST-Rab11a-Q70L,
GST-FMN2-eFSI and His6-mCherry-tagged Spir-2-linker proteins were expressed in Escherichia coli
Rosetta or Rosetta (DE3) pLysS (Merck Millipore, Novagen, Darmstadt, Germany). Bacteria were cul-
tured in LB medium (100 mg/l ampicillin, 30 mg/l chloramphenicol) at 37˚C until an A600 nm of OD
0.6–0.8. Protein expression was induced by 0.1 mM Isopropyl-b-D-thiogalactopyranoside (IPTG;
Sigma-Aldrich, Taufkirchen, Germany) and continued at 16–20˚C for 18–20 hr. Bacteria were har-
vested and lysed by ultra-sonication. Soluble proteins were purified by an A¨KTApurifier system (GE
Healthcare Life Sciences, Freiburg, Germany) using GSH-Sepharose 4B (GE Healthcare Life Sciences)
or Ni-NTA beads (Qiagen, Hilden, Germany) and size exclusion chromatography (High Load 16/60
Superdex 200; GE Healthcare Life Sciences). Proteins were concentrated by ultrafiltration using
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Table 2. Expression vectors employed in this study.
Construct Plasmid Description
Fragment boundaries
(restriction sites) Purification Purpose
Myc-Spir1-FL pcDNA3-Myc-hs-Spir1 Myc-hs-Spir1 aa 2 - 757
(BamHI / SacI)
Co-IP
Myc-Spir2-FL pcDNA3-Myc-hs-Spir2 Myc-hs-Spir2 aa 2 - 714
(BamHI / HindIII)
Co-IP
Myc-Spir2-KWM pcDNA3-Myc-hs-Spir2-
KIND-WH2-GTBM
Myc-hs-Spir2-KIND-
WH2-GTBM
aa 2 - 437
(BamHI / XhoI)
Co-IP,
Transient expression
Myc-Spir2-2-423 pcDNA3-Myc-hs-
Spir2-2-423
Myc-hs-Spir2-aa2-423 aa 2 - 423
(BamHI / XhoI)
Co-IP
Myc-Spir2-KW pcDNA3-Myc-hs-
Spir2-KIND-WH2
Myc-hs-Spir2-
KIND-WH2
aa 2 - 410
(BamHI / XhoI)
Co-IP,
Transient expression
Myc-Spir2-MSF pcDNA3-Myc-hs-
Spir2-GTBM-SB-FYVE
Myc-hs-Spir2-GTBM-
SB-FYVE
aa 361/398 - 728
(BamHI / XhoI)
Co-IP,
Transient expression
Myc-Spir2-411-714 pcDNA3-Myc-hs-
Spir2-411-714
Myc-hs-Spir2-
aa411-714
aa 411 - 714
(BamHI / XhoI)
Co-IP
Myc-Spir2-SF pcDNA3-Myc-hs-
Spir2-SB-FYVE
Myc-hs-Spir2-
SB-FYVE
aa 438 - 714
(BamHI / XhoI)
Co-IP,
Transient expression
Strawberry-
Spir2-MSF
pmStrawberry-C1-hs-
Spir2-GTBM-SB-FYVE
mStrawberry-hs-
Spir2-GTBM-SB-FYVE
aa 361 - 714
(EcoRI / KpnI)
Transient expression,
FLIM-FRET
Strawberry-
Spir2-SF
pmStrawberry-C2-
hs-Spir2-SB-FYVE
mStrawberry-
hs-Spir2-SB-FYVE
aa 438 - 714
(XhoI / BamHI)
Transient expression,
FLIM-FRET
Strawberry-
Spir2-MSF-LALA
pmStrawberry-C1-
hs-Spir2-GTBM-
SB-FYVE-LALA
mStrawberry-hs-
Spir2-GTBM-SB-
FYVE-L408A,L409A
aa 361 - 714
(EcoRI / XbaI)
Transient expression,
FLIM-FRET
GST-Spir2-MSF pGex-4T3-hs-Spir2-
GTBM-SB-FYVE
GST-hs-Spir2-
GTBM-SB-FYVE
aa 361 - 714
(BamHI / XhoI)
GSH-Sepharose 4B,
Superdex 200
GST-Pulldown
His-mCherry-
Spir2-linker
pProEx-HTb-mCherry-
hs-Spir2-linker
His6-mCherry-
hs-Spir2-linker
aa 361 - 519
(XhoI / HindIII)
Ni-NTA,
Superdex 200
GST-Pulldown,
Binding assays
His-mCherry-
Spir2-linker-LALA
pProEx-HTb-mCherry-
hs-Spir2-linker-LALA
His6-mCherry-hs-Spir2-
linker-L408A,L409A
aa 361-519
(mutagenesis)
Ni-NTA,
Superdex 200
GST-Pulldown
Spir2 / Fluorescein-
Spir2 peptide
aa 401-427 purchased from
GenScript
Crystallization,
Fluoresc. anisotropy
GFP-MyoVa-D-FL provided by
Bruno Goud
Lindsay et al., 2013 GST-Pulldown,
Transient expression
GFP-MyoVa-D-QR provided by
Bruno Goud
Lindsay et al., 2013 GST-Pulldown,
Transient expression
GFP-MyoVa-F-QR provided by
Bruno Goud
Lindsay et al., 2013 Transient expression
GFP-MyoVa-
CC-GTD
peGFP-C2-
mm-MyoVa-CC-GTD
eGFP-mm-MyoVa-
CC-GTD
aa 1260 - 1880
(EcoRI / SalI)
Transient expression
GFP-MyoVa-GTD pAcGFP-C1-
mm-MyoVa-GTD
AcGFP-mm-
MyoVa-GTD
aa 1467 - 1880
(HindIII / SalI)
Co-IP,
FLIM-FRET
Strawberry-
MyoVa-GTD
pmStrawberry-C1-
mm-MyoVa-GTD
mStrawberry-mm-
MyoVa-GTD
aa 1467 - 1880
(HindIII / SalI)
Transient expression,
FLIM-FRET
GST-MyoVa-GTD pGex-4T1-NTEV-
mm-MyoVa-GTD
GST-mm-MyoVa-GTD aa 1467 - 1880
(HindIII / SalI)
GSH-Sepharose 4B,
Superdex 200
GST-Pulldown,
Binding assays
MyoVa-GTD pProEx-HTb-hs-
MyoVa-GTD
hs-MyoVa-GTD aa 1461 - 1853
(BamHI / XhoI)
HisTrap, TEV,
Superdex 200
Crystallization, GST-
Pulldown, Anisotropy
GFP-MyoVb-
CC-GTD
pAcGFP-C1-
hs-MyoVb-CC-GTD
AcGFP-hs-
MyoVb-CC-GTD
aa 904 - 1848
(HindIII / SalI)
Co-IP
GFP-MyoVb-GTD pAcGFP-C1-
hs-MyoVb-GTD
AcGFP-hs-
MyoVb-GTD
aa 1467 - 1848
(HindIII / SalI)
Co-IP, FLIM-FRET,
Transient expression
GFP-MyoVb-GTD-
Q1748R
pAcGFP-C1-hs-
MyoVb-GTD-Q1748R
AcGFP-hs-MyoVb-
GTD-Q1748R
aa 1467 - 1848
(mutagenesis)
Transient expression
Table 2 continued on next page
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Amicon Ultra centrifugal filters (Merck Millipore, Darmstadt, Germany) with respective molecular
weight cut offs. The final protein purity was estimated by SDS-PAGE and Coomassie staining.
MyoVa-GTD, MyoVb-GTD, MyoVc-GTD and Rab11a-1-176 were produced and purified as previ-
ously described (Pylypenko et al., 2013). Briefly, the recombinant expression of MyoVb, MyoVa or
MyoVc GTD domains (residues 1456–1848, 1461–1853, 1350–1742 respectively) was performed in
Escherichia coli BL21(DE3) or BL21-CodonPlus-RILP cells using a pProEX-HTb vectors containing an
N-terminal 6xHis peptide and rTEV cleavage site. The Rab11a (1–176), His6-mCherry-Spir-2-linker
and Rab11a-Q70L (1–173) were produced using a pProEX-HTb or a pET28 modified vector contain-
ing N-terminal His6 tag and rTEV cleavage site in BL21(DE3) cells.
Bacterial cells were grown at 37˚C in 2YT medium induced at an A600 nm of OD 0.6 by the addi-
tion of 1 mM IPTG, and harvested after 18 hr at 20˚C. The cell pellet was resuspended in 50 mM Tris
pH 8.0, 300 mM NaCl, 2 mM MgCl2, 30 mM imidazole, 2 mM b-mercaptoethanol, 5% (v/v) glycerol
and protease inhibitor mix (Chymostatin, Leupeptin, Antipain, Pepstatin A at 1 mg/ml), lysed by soni-
cation, and centrifuged at 35,000 x g for 1 hr. The supernatant was loaded onto a HisTrap column
(GE Healthcare Life Sciences). After washing with the buffer, the fusion proteins were eluted with a
gradient of 30–500 mM imidazole. The His-tag was cleaved by incubation with rTEV protease at 1:50
molar ratio overnight. The protein was further purified by gel filtration on Superdex 200.
The synthetic Spir-2-401-427 fragment (QRPRPRVLLKAPTLAEMEEMNTSEEEE) and its N-termi-
nally fluorescein labeled analog: (5-FAM-Ahx-QRPRPRVLLKAPTLAEMEEMNTSEEEE) were purchased
from GenScript (Piscataway, NJ, USA).
Crystallization, data collection, structure determination
The crystallization experiments were performed at 17˚C by vapor diffusion in hanging drops. The
MyoVa-GTD:Rab11a complex was obtained by mixing the purified MyoVa-GTD and Rab11a in a 1:1
Table 2 continued
Construct Plasmid Description
Fragment boundaries
(restriction sites) Purification Purpose
GST-MyoVb-GTD pGex-4T1-NTEV-
hs-MyoVb-GTD
GST-hs-MyoVb-GTD aa 1467 - 1848
(BamHI / XhoI)
GSH-Sepharose 4B,
Superdex 200
GST-Pulldown,
Binding assays
MyoVb-GTD pProEx-HTb-hs-
MyoVb-GTD
hs-MyoVb-GTD aa 1456 - 1848
(BamHI / XhoI)
HisTrap, TEV,
Superdex G200
Crystallization, GST-
Pulldown, Anisotropy
MyoVc-GTD pProEx-HTb-hs-
MyoVc-GTD
hs-MyoVc-GTD aa 1350 - 1742
(BamHI / XhoI)
HisTrap, TEV,
Superdex 200
Microscale thermophoresis
Strawberry-
Rab11a
pmStrawberry-C1-
mm-Rab11a
mStrawberry-
mm-Rab11a
aa 2 - 216
(EcoRI / BamHI)
Transient expression
GST-Rab11a-Q70L pGex-4T1-NTEV-
cl-Rab11a-Q70L
GST-cl-Rab11a-Q70L aa 1 - 216
(EcoRI / EcoRI)
GSH-Sepharose 4B,
Superdex 200
GST-Pulldown
Rab11a pET28-rTEV-
hs-Rab11a
hs-Rab11a aa 1 - 177
(NcoI / EcoRI)
HisTrap, TEV,
Superdex 200
Crystallization, SPR
Rab11a-Q70L pET28-rTEV-
hs-Rab11a-Q70L
hs-Rab11a-Q70L aa 1 - 173
(NcoI / EcoRI)
HisTrap, TEV,
Superdex 200
GST-Pulldown
Strawberry-FMN2-
FH2-FSI
pmStrawberry-C2-
mm-FMN2-FH2-FSI
mStrawberry-mm-
FMN2-FH2-FSI
aa 1135 - 1578
(BamHI / XhoI)
GST-Pulldown
GST-FMN2-eFSI pGex-4T1-NTEV-
mm-FMN2-eFSI
GST-mm-FMN2-eFSI aa 1523 - 1578
(BamHI / XhoI)
GSH-Sepharose FF,
Superdex 200
GST-Pulldown
from brain lysates
GFP pAcGFP-C1 AcGFP Co-IP,
FLIM-FRET
GFP-linker-
Strawberry
pAcGFP-C1-linker-
mStrawberry
AcGFP-linker(A-S-
G-A-G)-mStrawberry
aa 1 - 236
(BspEI / BglII)
FLIM-FRET
mCherry pProEx-HTb-mCherry His6-mCherry aa 1 - 236
(BamHI / XhoI)
Ni-NTA,
Superdex 200
GST-Pulldown
GST pGex-4T1-NTEV GST GSH-Sepharose 4B,
Superdex 200
GST-Pulldown
DOI: 10.7554/eLife.17523.021
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molar ratio to a 12 mg/ml final concentration supplemented with 2 mM beryllium fluoride. Crystals
of the MyoVa-GTD:Rab11a complex were grown in 7% (w/v) PEG-8000, 50 mM Bicine, 50 mM Tris,
30 mM NaCl, 20% (v/v) ethylene glycol. The MyoVa-GTD:Spir-2 complex, obtained by mixing
MyoVa-GTD with Spir-2-401-427 peptide in 1:3 molar ratio at final protein concentration 20 mg/ml,
was crystallized in 50 mM Hepes, 50 mM MOPS, 10% (w/v) PEG 1000, 10% (w/v) PEG 3350, 10% (v/
v) MPD. Native data sets were collected to 1.8 A˚ and 2 A˚ resolution for MyoVa-GTD:Spir2 complex
and MyoVa-GTD:Rab11a complex crystals respectively at Soleil synchrotron PX1 beamline.
The crystals were flash frozen in liquid nitrogen. The X-ray diffraction data were indexed, inte-
grated, and scaled with the XDS program suite (Kabsch, 2010). The structures were solved by
molecular replacement with Molrep (Vagin and Teplyakov, 2010) using MyoVa-GTD structure (PDB
ID 4LX1) as a search model. The models were iteratively manually rebuilt with COOT (RRID: SCR_
014222) (Emsley and Cowtan, 2004), and refined with BUSTER (Bricogne et al., 2011) and PHENIX
(RRID: SCR_014224) (Adams et al., 2010). The data collection and refinement statistics are summa-
rized in Table 1.
Analytical gel filtration
Complex formations were analyzed by analytical gel-filtration using Superdex 200 10/30 Increase
column (GE Healthcare Life Sciences) and UV light absorbance at 280 nm and 260 nm and Visible
light absorbance at 587 nm at flow rate of 0.75 ml/min in 50 mM Tris pH 8.0, 150 mM NaCl, 2 mM
MgCl2, 2 mM TCEP buffer. Fractions of 500 ml were collected and analyzed by SDS-PAGE.
A 100 ml sample of His6-Rab11a-1-173-Q70L at 6 mg/ml, or of MyoVa-GTD at 5 mg/ml or of His6-
mCherry-Spir-2-linker at 6 mg/ml were centrifuged at 10,000 x g for 10 min and injected into the col-
umn to monitor reference elution profiles of the individual proteins. The proteins were mixed pair-
wise to the same final concentrations and incubated 30 min at 4˚C in a total volume of 100 ml. The
two-component complexes (His6-mCherry-Spir-2-linker:MyoVa-GTD and MyoVa-GTD:His6-Rab11a-1-
173-Q70L) were confirmed by the elution peak shifts and SDS-PAGE analysis. No change in migra-
tion of the individual proteins was observed for the His6-mCherry-Spir-2-linker and His6-Rab11a-1-
173-Q70L mix. The tripartite His6-mCherry-Spir-2-linker:MyoVa-GTD:His6-Rab11a-1-173-Q70L com-
plex was analyzed at the same concentration of the individual components and confirmed by SDS-
PAGE.
His6-mCherry-Spir-2-linker protein was eluted from the gel-filtration column in a single peak but it
migrated on SDS-PAGE as three bands with the major band size corresponding to a higher molecu-
lar weight than expected (theoretical molecular weight 47 kDa, apparent molecular weight 55 kDa).
The purified His6-mCherry-Spir-2-linker protein was analyzed by peptide mass fingerprinting using
LC-MS/MS identification approach at Curie Institute Protein Mass Spectrometry Platform. All three
bands were identified as His6-mCherry-Spir-2-linker protein or its fragments. The 55 kDa SDS-PAGE
His6-mCherry-Spir-2-linker band corresponded to a full-length construct with 65% peptide coverage
evenly distributed over the protein sequence, the minor 45 kDa and 12 kDa band species corre-
sponded to His6-mCherry-Spir-2-linker degradation products.
Cell culture
HEK293 (ATCC Cat# CRL-1573, RRID: CVCL_0045) and HeLa cells (ATCC Cat# CCL-2, RRID: CVCL_
0030) were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; ThermoFisher) supplemented
with 10% (v/v) fetal calf serum (FCSIII; GE Healthcare Life Sciences, HyClone), 2 mM L-glutamine,
penicillin (100 units/ml) and streptomycin (100 mg/ml) at 37˚C, 5% CO2, 95% humidity and were pas-
saged regularly at 80% confluency. Transfections with plasmid DNA were performed using Lipofect-
amine reagent (ThermoFisher) according to manufacturer’s recommendation.
Co-immunoprecipitation
HEK293 cells were transfected with expression vectors encoding Myc-tagged Spir proteins and GFP-
tagged myosin Va and myosin Vb fragments. 48 hr post transfection, cells were lysed in lysis buffer
(25 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM MgCl2, 10% (v/v) glycerol, 0.1% (v/v) Nonidet P-40, 1
mM Phenylmethylsulfonylfluorid (PMSF; Sigma-Aldrich), protease inhibitor cocktail (complete mini,
EDTA-free; Roche, Penzberg, Germany)) and centrifuged at 20,000 x g, 4˚C, 20 min to remove insol-
uble debris. The clarified supernatant was incubated with 4 mg anti-c-Myc antibody (9E10, mouse
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monoclonal; Santa Cruz Biotechnology; RRID: AB_627268) for 1 hr on ice. Subsequently, 40 ml Pro-
tein G-Agarose beads (1:1 suspension; Roche) were added and incubated for 2 hr at 4˚C on a rotat-
ing wheel. Beads were washed with pulldown buffer (25 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM
MgCl2, 10% (v/v) glycerol, 0.1% (v/v) Nonidet P-40). Bound proteins were eluted with 1x Laemmli
buffer and denatured for 10 min at 95˚C, then analyzed by immunoblotting.
GST-pulldown from HEK293 lysates
HEK293 cells were co-transfected with expression vectors encoding Myc-Spir-2-FL, mStrawberry-
FMN2-FH2-FSI, eGFP-MyoVa-D-FL and eGFP-MyoVa-D-Q1753R, respectively. 24 hr post transfec-
tion, cells were lysed in lysis buffer (25 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM MgCl2, 10% (v/v)
glycerol, 0.1% (v/v) Nonidet P-40, 1 mM PMSF, protease inhibitor cocktail) and centrifuged at
20,000 x g, 4˚C, 20 min to remove insoluble debris. For GST-pulldown assays 65 mg GST-Rab11a-
Q70L protein (25 mg GST control) was coupled to GSH-Sepharose 4B beads (1:1 suspension) for 1
hr, 4˚C on a rotating wheel. Beads were washed twice with pulldown buffer (25 mM Tris-HCl pH 7.4,
150 mM NaCl, 5 mM MgCl2, 10% (v/v) glycerol, 0.1% (v/v) Nonidet P-40) and subsequently incu-
bated with the cell lysates for 2 hr at 4˚C on a rotating wheel. Beads were washed four times with
pulldown buffer and bound proteins were eluted with 1x Laemmli buffer and denatured at 95˚C for
10 min, then were analyzed by immunoblotting.
GST-pulldown from mouse brain
Wild-type C57BL/6 (Jackson Laboratory, Bar Harbor, ME, USA) mice were killed by cervical disloca-
tion. The brain was isolated immediately, washed in cold PBS and lysed in lysis buffer (25 mM Tris-
HCl pH 7.4, 150 mM NaCl, 5 mM MgCl2, 10% (v/v) glycerol, 0.1% (v/v) Nonidet P-40, 0.1 M NaF, 1
mM Na3VO4, 1 mM PMSF, protease inhibitor cocktail) using a TissueRuptor (Qiagen). Following incu-
bation on ice for 45 min, the lysate was centrifuged at 20,000 x g, 4˚C until the supernatant was
clear. Brain lysates were incubated with GSH-Sepharose 4B beads, loaded with 50 mg GST-fusion
proteins as indicated, for 2.5 hr at 4˚C on a rotating wheel. Beads were washed five times with pull-
down buffer and bound proteins were eluted by 1x Laemmli buffer and denatured at 95˚C for 10
min. Pulled proteins were analyzed by immunoblotting.
GST-pulldown experiments with purified proteins
For GST-pulldown assays, 50 mg of GST-fusion protein was coupled to GSH-Sepharose 4B beads
(1:1 suspension) for 1 hr at 4˚C on a rotating wheel. Beads were washed twice with pulldown buffer
and subsequently incubated with 20 mg His6-mCherry-fusion peptides for 2 hr, 4˚C on a rotating
wheel. In order to identify the tripartite Spir-2:MyoVa:Rab11a complex, 65 mg GST-Spir-2-GTBM-SB-
FYVE was coupled to beads. Subsequently, beads were incubated with 40 mg MyoVa-GTD and 35
mg Rab11a-Q70L simultaneously for 2 hr. Beads were washed four times with pulldown buffer and
bound proteins were eluted by 1x Laemmli buffer and denatured at 95˚C for 10 min. Pulled proteins
were analyzed by immunoblotting.
Quantitative GST-pulldown assays
GST-pulldown assays were performed as described above with increasing concentrations of GST-
MyoVa/b-GTD fusion proteins and 100 nM His6-mCherry-Spir-2-linker peptide in SPECS buffer (1x
PBS, 50 mM NaCl). Beads were pelleted and the supernatant was centrifuged for 10 min at 20,000 x
g to remove potential debris that could disturb the fluorescence measurement. Each protein sample
was allowed to adapt to 20˚C for 15 min in a water bath. The concentration-dependent binding of
MyoVa/b-GTD to the Spir-2-linker was determined by fluorospectrometric analysis using FluoroMax-
4 Spectrofluorometer (Horiba Jobin Yvon, Bensheim, Germany). The mCherry red fluorescent protein
was excited at 548 nm and the emission at 610 nm was recorded (emission maximum). The data
were calculated as ’fraction bound’ (y) compared to the initial fluorescence signal without any GST-
MyoV-GTD protein
y¼ 1 
y0  yc
y0
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With y0 is fluorescence signal without GST-MyoV-GTD and yc is signal at corresponding GST-
MyoV-GTD concentration.
Furthermore, data were analyzed in SigmaPlot 12.3 software (Systat Software, Erkrath, Germany).
Equilibrium binding data were fitted according to the equation
y¼
Bmax  x
Kd þ x
assuming a single binding site and with Bmax representing the maximal amplitude, Kd representing
the equilibrium constant and x representing the concentration of GST-MyoV-GTD.
The binding curves saturated at 40% since the His6-mCherry-Spir-2-linker protein preparation
contained C-terminal incomplete protein products, which are still fluorescent but cannot interact
with MyoV-GTD. The Spir-2-linker region is predicted to be highly unstructured, which may be the
reason for the relative instability of the recombinant His6-mCherry-Spir-2-linker fusion protein.
Surface plasmon resonance binding assay
The assays were carried out at 25˚C in buffer (50 mM Hepes pH 7.5, 100 mM NaCl, 2 mM MgCl2, 1
mM TCEP). 200–250 resonance units (RU; 1RU » 1 pg  mm 2) of Rab11a-Q70L(GTP) or Rab11-wt
(GDP) were captured through their His6-tag on the surface of a NTA sensorchip using a Biacore
2000 instrument (GE Healthcare Life Sciences). MyoVa-GTD or MyoVb-GTD (10 nM–5 mM) were then
injected over the tethered Rabs for one minute at a flow rate of 50 ml/min. The surface was regener-
ated with a 2-min 0.3 M EDTA incubation and a 1-min 0.1% SDS wash. The real-time interaction pro-
files were double referenced using the Scrubber 2.0 software (BioLogic
Software, Campbell, Australia), both the signals from a reference surface (with a non-relevant protein
captured on NTA) and from blank experiments using buffer instead of MyoV-GTD were subtracted.
The MyoV-GTD concentration-dependence of the steady-state SPR signals was then analyzed to
determine the dissociation equilibrium constants (Kd) of the different complexes using the numerical
integration algorithm software Biaevaluation 4.1. Each experiment (10 point 2-fold dilution concen-
tration series each) was repeated in triplicate, yielding mean Kd values and standard errors (SEM).
Fluorescence anisotropy measurements
Fluorescence anisotropy measurements were performed on a PTI Quanta-Master QM4CW spectro-
fluorometer (PTI, Lawrenceville, NJ, USA) at 25˚C using a 10 mm wide quartz cell. Bandwidths of
excitation and emission monochromators were set respectively at 5 and 15 nm. Fluorescence anisot-
ropy, expressed in millianisotropy units, was calculated according to the equation
A¼
IVV  GIVH
IVV þ 2GIVH
with A is anisotropy, G ¼ IHV=IHH is a correction factor for wavelength-dependent distortion, and I
is the fluorescence intensity component. Anisotropy values were averaged from 30 different acquisi-
tions. The cell was charged with 1 mM of fluorescein labeled Spir-2-401-427 peptide in a final volume
of 1 ml in buffer (100 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM MgCl2, 2 mM TCEP, 5% (v/v) glyc-
erol) and titrated with MyoVa-GTD or MyoVb-GTD (50 nM–5 mM). The binding isotherms were fitted
to obtain the equilibrium dissociation constants Kd and standard errors, by using the Origin 2015
software that implements Levenberg Marquardt iterative minimization algorithms, using the
equation
y¼ F0þ
Fm F0
2P
Pþ xþKd  
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Pþ xþKdð Þ
2 4Px
q 
with y represents the fluorescence anisotropy, x the concentration of MyoV-GTD, F0 the initial anisot-
ropy, Fm the maximum anisotropy, and P the peptide concentration. Experiments were repeated
twice with two different protein preparations.
Microscale thermophoresis measurements (MST)
MST experiments were performed on a Monolith NT.115 system (NanoTemper
Technologies, Mu¨nchen, Germany) using 5% LED and 30% IR-laser power at 21.5˚C. Laser on and off
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times were set at 30 s and 5 s, respectively. Fluorescein labeled Spir-2 peptide was synthesized by
Genscript, the peptide was dissolved in PBS with 0.005% Tween-20 and diluted to 1 mM concentra-
tion. A two-fold dilution series was prepared for the MyoVc-GTD in the interaction buffer (50 mM
Tris pH 8.0, 250 mM NaCl, 2 mM MgCl2, 2 mM TCEP, 5% (v/v) glycerol) and each dilution point was
transferred to the Fluorescein-Spir-2 solution. The final concentrations of MyoVc-GTD ranged from
97 mM to 2.96 nM, the final concentration of the labeled peptide was 500 nM. Samples were filled
into premium capillaries (NanoTemper Technologies) for measurements. The experiments were per-
formed with three independent replicates. The affinity was quantified by analyzing the change in
normalized fluorescence as a function of the concentration of the titrated peptide using the NTAnal-
ysis software provided by the manufacturer.
Immunoblotting
Proteins were separated by SDS-PAGE and analyzed by Western blotting using anti-GFP (Living Col-
ors A.v. peptide antibody, rabbit polyclonal, 1 mg/ml; Clontech; RRID: AB_2313653), anti-RFP (Living
Colors DsRed rabbit polyclonal antibody, 0.5 mg/ml; Clontech; RRID: AB_10015246), anti-c-Myc
(9E10, mouse monoclonal, 0.4 mg/ml; Santa Cruz Biotechnology; RRID: AB_627268), anti-Spir-1
(SA2133, rabbit polyclonal, 0.5 mg/mL (Schumacher et al., 2004); RRID: AB_2619680), anti Rab11
(D4F5 XP, rabbit monoclonal, 1:1000; Cell Signaling Technology, #5589; RRID: AB_10693925) and
anti-myosin Va (rabbit polyclonal, 1:750; Cell Signaling Techology, #3402; RRID: AB_2148475) anti-
bodies, horseradish peroxidase linked anti-rabbit IgG (from donkey; RRID: AB_772206) and anti-
mouse IgG (from sheep; RRID: AB_772210) secondary antibodies (1:5000, GE Healthcare). Proteins
were visualized by chemiluminescence (Luminata Forte Western HRP substrate; Merck Millipore).
The signal was recorded with an Image Quant LAS4000 system (GE Healthcare Life Sciences).
Recorded images were processed in Adobe Photoshop and assembled in Adobe Illustrator.
Immunostaining
HeLa cells were seeded on microscope cover glasses and transfected with Myc-epitope-tagged Spir-
2 proteins and fluorescently-tagged MyoV and Rab11 proteins as described above. Cells were fixed
with paraformaldehyde (3.7% in 1x PBS) for 20 min at 4˚C and subsequently permeabilized using
0.2% Triton X-100 (in 1x PBS) for 3.5 min, room temperature. Cells were incubated with anti-c-Myc
antibody (9E10, mouse monoclonal, 2 mg/ml, Santa Cruz Biotechnology; RRID: AB_627268) for 1 hr
at room temperature and conjugated anti-mouse secondary antibodies (Cy5; from donkey, 3.25 mg/
ml, Dianova (RRID: AB_2340820) and TRITC; from donkey, 3.125 mg/ml, Dianova (RRID: AB_
2340767)) for 1 hr at room temperature avoiding exposure to light. Finally, cells were mounted on
microscope slides with Mowiol and analyzed with a Leica AF6000LX fluorescence microscope,
equipped with a Leica HCX PL APO 63x/1.3 GLYC objective and a Leica DFC350 FX digital camera
(1392  1040 pixels, 6.45  6.45 mm pixel size). 3D stacks were recorded and processed with the
Leica deconvolution software module. In case of the MyoVa autoregulation/activation experiments,
we quantified the MyoVa expression levels. High expression of GFP-MyoVa-D-FL induced vesicular
localization, whereas an even cytoplasmic distribution was observed at low expression levels. In
order to clearly distinguish between vesicular and cytoplasmic MyoVa localization, we imaged either
high or low expressing cells and determined the sum of pixel gray values per cell as a measure for
the MyoVa expression levels. Based on that, we only used cells for the autoregulation analysis having
a sum of pixel gray values less than 20  106 for the expression of GFP-MyoVa-D-FL. Images were
recorded using the Leica LASX software and further processed with Adobe Photoshop and subse-
quently assembled with Adobe Illustrator.
Time-correlated single-photon counting fluorescence lifetime
microscopy (TCSPC-FLIM)
Fluorescence lifetimes were imaged with a commercial FLIM upgrade kit (PicoQuant, Berlin, Ger-
many) attached to a confocal microscope LSM 880 (Zeiss, Jena, Germany) using a 440 nm pulsed
laser diode at 20 MHz repetition rate. The fluorescence was detected using the Big.2-unit (Zeiss) fed
into the TimeHarp 260 photon counting board (PicoQuant). Time series of FLIM images were
recorded until bright pixels accumulated at least 1000 photon events. Before pixel wise fitting (Sym-
photime, 64-bit, version 2, PicoQuant), a region of interest was defined manually by setting a
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threshold for selecting pixels of high intensity (100–300 photon events per pixel). Fitting employed
an exponential two-component model to 20 ns of the decay without binning. Lifetime images con-
tained the color coded, intensity weighted average in each pixel.
For an improved automated selection of vesicular structures in cells, we followed a previously
established semi-automated approach (Austen et al., 2015). Briefly, confocal imaging was done
using a Leica TCS SP5 X confocal microscope equipped with a pulsed white light laser (WLL, 80 MHz
repetition rate; NKT Photonics, Birkerod, Denmark), a FLIM X16 TCSPC detector (LaVision
Biotec, Bielefeld, Germany) and a 63x water objective (HCX PL APO CS, NA = 1.2). A band-pass fil-
ter 514/30 (AHF Analysentechnik, Tu¨bingen, Germany) was used to block acceptor emitted photons.
Data analysis includes manual selection of the cytoplasmic regions followed by a threshold algo-
rithm, segmenting high intensity regions based on spatial signal changes at varying levels. The cus-
tom-written MATLAB program (Austen et al., 2015) calculates the average FRET efficiency E
according to
E ¼ 1 
tDA
tD
with tD as the mean donor lifetime tDA as mean donor lifetime in presence of an acceptor fluoro-
phore. E represents the entire ROI of a single cell. Here, fitting employed an exponential one-com-
ponent fit to 10 ns of decay; the first 0.5 ns were omitted due to the instrumental response.
Measurements on both instruments, as well as the use of different ROI settings (e.g. cytoplasm with
or without threshold excluded regions) reproduced consistent results for three independent
experiments.
Colocalization analysis
The extent of colocalization of Rab11, Spir-2 and MyoVa was analyzed using the ImageJ (V2.0.0)
plug-in Coloc 2. Here, the colocalization rate is indicated by the Pearson’s Correlation Coefficient
(PCC) as a statistical measure to unravel a linear correlation between the intensity of different fluo-
rescent signals. A PCC value of 1 indicates a perfect colocalization, 0 indicates a random colocaliza-
tion and a PCC value of -1 indicates a mutually exclusive localization of the analyzed signals. To take
the noise of each image into account and to gain an objective evaluation of PCC significance, a
Costes significance test was performed. Therefore, the pixels in one image were scrambled ran-
domly and the correlation with the other (unscrambled) image was measured. Significance regarding
correlation was observed when at least 95% of randomized images show a PCC less than that of the
original image, meaning that the probability for the measured correlation of two colors is signifi-
cantly greater than the correlation of random overlap (Costes et al., 2004; Pompey et al., 2013).
Statistical data analysis was performed using SPSS 22 (IBM, Armonk, NY, USA).
Accession numbers
The atomic coordinates and structure factors have been deposited in the Protein Data Bank, www.
pdb.org, with accession numbers 5JCY (MyoVa-GTD:Spir-2-GTBM), 5JCZ (MyoVa-GTD:Rab11), see
Table 1.
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